Versant HIV-1 Assay Approval Could Cut Lab Labor In Half – Bayer
This article was originally published in The Gray Sheet
Executive Summary
Bayer Diagnostics' Versant HIV-1 RNA 3.0 assay is the first viral load test approved by FDA that can detect any clinically significant change in HIV-1 in one test-run, the company claims
You may also be interested in...
Bayer's $1.1 Bil. Chiron Diagnostics Buy Adds Blood Gas Analyzer Line
Acquisition of Chiron Diagnostics for $1.1 bil. provides Bayer with an entry into the blood gas analysis market, broadens clinical laboratory systems offerings and will accelerate development efforts in the field of nucleic acid diagnostics.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.